scanX
GlaxoSmithKline Pharmaceuticals
add_icon

GlaxoSmithKline Pharmaceuticals

2,121.50
+18.30
(0.87%)
Market Cap
35,939.49 Cr
PE Ratio
34.39
Volume
3,57,494.00
Day High - Low
2,131.90 - 2,088.10
52W High-Low
3,500.00 - 2,096.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
35,939.49 Cr
EPS
61.15
PE Ratio
34.39
PB Ratio
15.71
Book Value
133.85
EBITDA
1,454.60
Dividend Yield
2.71 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
45.69
Debt to Equity
0.01
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+75.00 %
+75.00 %
Hold
Hold+25.00 %
+25.00 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
GSK Pharma releases FY26 annual report weblink6 days ago
GlaxoSmithKline Pharmaceuticals Limited provided the weblink for its FY26 annual report. Shareholders without registered emails must access it online. Payments are withheld for unverified KYC.
neutral
GSK Pharma submits BRSR for FY269 days ago
GlaxoSmithKline Pharmaceuticals filed its Business Responsibility and Sustainability Report for FY26. The report details CSR spending of ₹1,859.48 Lakhs and a 10.32% reduction in GHG emissions.
positive
GSK Pharma announces ₹57 dividend for FY26Jun 02, 2026
GlaxoSmithKline Pharmaceuticals Limited has recommended a dividend of ₹57 per share for the year ended March 31, 2026. The 101st AGM is scheduled for June 30, 2026, via video conferencing.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,807.70
#1 4,33,727.78
37.40
#1 58,220.10
6.38
#1 11,565
25.80
51.01
Divis Laboratories
6,638.00
1,76,218.04
68.76
10,560.00
8.73
2,520
13.44
50.29
Torrent Pharmaceuticals
4,571.20
1,54,710.18
72.33
13,886.20
20.34
2,138
-26.91
61.51
Cipla
1,389.40
1,12,233.05
28.93
29,044.60
2.24
3,870
-55.32
54.93
Zydus Life Science
1,104.70
1,11,158.67
21.71
26,719.70
13.65
5,242
7.82
71.11
Dr Reddys Laboratories
1,275.40
1,06,450.37
25.60
33,593.30
-0.44
3,998
-86.05
45.75
Lupin
2,293.30
1,04,813.72
#1 19.41
27,487.50
19.98
5,345
#1 87.72
53.15
Mankind Pharma
2,381.10
98,293.02
50.54
14,277.60
12.03
1,750
31.75
51.93
Aurobindo Pharma
1,472.80
85,540.46
24.28
33,384.70
3.21
3,376
1.99
56.54
Laurus Labs
1,394.30
75,272.20
84.38
6,812.90
#1 21.03
884
21.18
62.27
Growth Rate
Revenue Growth
1.85 %
Net Income Growth
11.69 %
Cash Flow Change
-29.97 %
ROE
-3.89 %
ROCE
-3.30 %
EBITDA Margin (Avg.)
7.95 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
754
831
871
823
819
1,299
795
803
707
888
834
785
764
964
838
2,132
776
939
826
826
815
985
833
962
850
1,050
985
1,015
849
1,016
1,091
1,031
Expenses
608
663
688
588
623
688
1,408
602
535
739
611
707
586
678
636
634
596
660
585
618
618
668
751
673
584
689
658
641
554
644
670
644
EBITDA
145
168
183
236
196
611
-613
201
172
150
223
78
178
286
202
1,497
180
279
241
208
198
318
83
290
266
361
327
374
295
372
421
387
Operating Profit %
17 %
19 %
17 %
22 %
21 %
22 %
-81 %
22 %
18 %
16 %
23 %
5 %
18 %
27 %
22 %
22 %
20 %
28 %
27 %
22 %
19 %
30 %
7 %
28 %
28 %
32 %
31 %
34 %
31 %
34 %
36 %
35 %
Depreciation
11
12
12
14
19
23
18
23
22
22
18
18
18
17
18
15
16
16
16
17
16
18
17
18
16
17
19
15
16
17
20
13
Interest
0
0
0
0
1
1
3
2
1
1
1
1
1
0
1
0
1
0
0
1
0
0
0
1
0
0
0
1
0
1
1
1
Profit Before Tax
134
157
171
222
176
587
-634
177
149
127
204
60
160
268
184
1,482
163
262
224
190
181
299
65
271
249
344
308
359
279
354
400
373
Tax
50
56
57
75
63
85
27
39
38
51
48
45
39
64
34
263
44
69
60
57
49
82
20
76
67
91
78
96
74
97
104
95
Net Profit
84
101
114
147
114
503
-661
138
111
77
157
14
121
204
150
1,219
119
193
165
133
132
218
46
195
182
253
230
263
205
258
296
278
EPS in ₹
9.93
5.95
6.71
8.67
6.70
29.68
-39.03
8.15
6.54
4.51
10.26
0.85
7.14
12.06
8.87
71.96
7.04
11.42
9.71
7.41
7.04
12.84
9.89
11.37
10.76
14.67
13.57
15.52
12.10
15.07
16.54
16.40
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
3,216
3,055
3,004
3,948
3,911
3,136
3,115
4,633
3,327
3,557
4,108
4,324
Fixed Assets
123
210
258
325
432
758
387
331
330
321
284
281
Current Assets
2,587
2,174
1,674
2,186
2,010
1,775
2,203
3,708
2,494
2,798
3,410
3,606
Capital Work in Progress
115
268
606
923
1,003
120
13
31
20
14
14
33
Investments
0
0
0
0
0
0
0
366
518
813
1,118
1,392
Other Assets
2,977
2,577
2,140
2,700
2,477
2,257
2,715
3,907
2,458
2,408
2,692
2,618
Total Equity & Liabilities
3,216
3,055
3,004
3,948
3,911
3,136
3,115
4,633
3,327
3,557
4,108
4,324
Current Liabilities
1,107
579
720
1,600
1,454
1,024
1,355
1,698
1,326
1,525
1,905
1,779
Non Current Liabilities
280
292
277
290
317
291
282
272
259
254
252
277
Total Equity
1,829
2,183
2,007
2,057
2,140
1,821
1,478
2,663
1,741
1,778
1,951
2,267
Reserve & Surplus
1,744
2,099
1,922
1,973
1,970
1,651
1,309
2,494
1,572
1,608
1,782
2,098
Share Capital
85
85
85
85
169
169
169
169
169
169
169
169
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
21
-0
24
62
-102
6
300
-119
-251
29
475
563
Investing Activities
180
499
301
-104
-153
-57
418
-406
808
9
-46
397
Operating Activities
338
139
234
473
410
491
578
811
484
582
1,290
903
Financing Activities
-497
-638
-511
-307
-358
-428
-696
-524
-1,543
-562
-769
-737
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.48 %
4.02 %
4.36 %
4.50 %
4.52 %
4.89 %
4.80 %
4.64 %
4.62 %
DIIs
5.31 %
5.51 %
5.50 %
5.61 %
5.61 %
4.08 %
10.45 %
10.28 %
10.30 %
10.23 %
10.01 %
8.53 %
7.90 %
7.50 %
7.34 %
7.30 %
7.79 %
7.70 %
7.75 %
7.70 %
7.68 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.02 %
10.86 %
10.83 %
10.67 %
10.41 %
10.41 %
10.40 %
10.56 %
10.54 %
10.57 %
10.62 %
11.08 %
11.27 %
11.15 %
10.97 %
10.96 %
10.60 %
10.32 %
10.34 %
10.36 %
10.35 %
Others
8.67 %
8.62 %
8.67 %
8.73 %
8.98 %
10.51 %
4.15 %
4.16 %
4.16 %
4.20 %
4.37 %
5.38 %
2.35 %
2.33 %
2.33 %
2.23 %
2.09 %
2.09 %
2.11 %
2.30 %
2.35 %
No of Share Holders
1,19,951
1,20,476
1,21,445
1,23,480
1,10,141
1,12,964
1,16,651
1,20,127
1,20,415
1,19,032
1,15,266
1,14,663
1,18,994
1,18,515
1,19,228
1,19,625
1,21,885
1,23,629
1,22,904
1,22,460
1,21,763

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 30 35 20 40 30 90 32 32 54 57
Dividend Yield (%) 2.87 2.7 1.59 2.78 1.8 7.05 1.64 1.11 2.37 2.69

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Jun 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 30 Jun 2026 2,448.80 2,121.50
13 Sept 2018 BONUS Bonus
1:1
 11 Sept 2018 1,726.60 1,724.70
20 Jul 2021 DIVIDEND Dividend
₹ 30.00 /share
 19 Jul 2021 1,518.15 1,607.55
08 Jul 2022 DIVIDEND Dividend
₹ 30.00 /share
 07 Jul 2022 1,493.30 1,505.90
08 Jul 2022 DIVIDEND Dividend
₹ 60.00 /share
 07 Jul 2022 1,493.30 1,505.90
26 Jul 2022 ANNUAL GENERAL MEETING Annual General Meeting
NA
 26 Jul 2022 1,493.30 1,493.85
30 Jun 2023 DIVIDEND Dividend
₹ 32.00 /share
 30 Jun 2023 1,289.55 1,438.20
31 May 2024 DIVIDEND Dividend
₹ 32.00 /share
 31 May 2024 2,023.85 2,593.00
28 Jun 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 28 Jun 2024 2,023.85 2,677.55
29 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 29 Oct 2024 2,630.85 2,644.65
07 Nov 2024 DIVIDEND Dividend
₹ 12.00 /share
 07 Nov 2024 2,644.65 2,632.20
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 14 Feb 2025 2,077.20 1,998.80
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 May 2025 2,928.60 2,721.25
30 May 2025 DIVIDEND Dividend
₹ 42.00 /share
 30 May 2025 2,721.25 3,263.40
27 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 27 Jun 2025 2,721.25 3,301.90
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 01 Aug 2025 3,262.85 3,158.15
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Nov 2025 2,758.10 2,661.50
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 09 Feb 2026 2,457.05 2,484.00
13 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 May 2026 2,427.40 2,448.80
29 May 2026 DIVIDEND Dividend
₹ 57.00 /share
 29 May 2026 2,448.80 2,301.05

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Letter For Website Link For Annual Report6 days ago
AGM Notice For 2025-269 days ago
Business Responsibility and Sustainability Reporting (BRSR)9 days ago
Reg. 34 (1) Annual Report.9 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 18, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2026
Corporate Action-Board approves DividendMay 13, 2026
Record Date For Final Dividend 29Th May 2026May 13, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 13, 2026
AGMMay 13, 2026
Corporate Action-Board approves DividendMay 13, 2026
Outcome Of MeetingMay 13, 2026
Board Meeting Outcome for Outcome Of Board MeetingMay 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 22, 2026
Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Year Ended 31St March 2026 And Dividend If Any Apr 22, 2026
Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015Apr 21, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 08, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 08, 2026
Disclosure Under Regulation 30Mar 31, 2026
Closure of Trading WindowMar 25, 2026
Disclosure Under Regulation 30Mar 24, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 16, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 11, 2026
Postal Ballot NoticeMar 07, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 07, 2026
Disclosure Under Regulations 30Mar 07, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 02, 2026
Board Meeting Outcome for Outcome Of Board MeetingMar 02, 2026
Disclosure Under Regulations 30Feb 28, 2026
Disclosure Under Regulation 30Feb 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 09, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2026
Financial Results For Quarter & Nine Months December 2025Feb 09, 2026
Board Meeting Outcome for Outcome Of MeetingFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
1.78%
3000
0.01%
-0.06%
Nippon India Nifty 500 Quality 50 Index Fund Direct-Growth
1.43%
-219
-0.10%
-0.30%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.23%
93
-0.02%
-0.04%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.23%
83
-0.02%
-0.04%
JioBlackRock Sector Rotation Fund Direct-Growth
0.07%
78
0.01%
-0.01%
Tata BSE Quality Index Fund Direct-Growth
0.99%
38
-0.07%
-0.19%
Aditya Birla Sun Life BSE 500 Quality 50 Index Fund Direct-Growth
0.77%
31
-0.05%
-0.15%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
0.23%
31
-0.02%
-0.03%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.07%
12
-0.02%
0.07%
DSP Nifty Midcap 150 Index Fund Direct-Growth
0.23%
11
-0.02%
-0.04%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.15%
10
-0.01%
-0.03%
Axis Nifty500 Quality 50 Index Fund Direct-Growth
1.39%
7
-0.11%
-0.31%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.11%
6
-0.02%
0.11%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.08%
5
-0.01%
0.08%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.05%
2
0.00%
0.00%
Groww Nifty Midcap 150 Index Fund Direct-Growth
0.23%
1
-0.02%
-0.05%
DSP Nifty 500 Index Fund Direct-Growth
0.05%
1
0.00%
0.00%
Baroda BNP Paribas Midcap Fund Direct-Growth
1.33%
0
0.00%
-0.12%
Mahindra Manulife Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Large and Mid Cap Fund Direct-Growth
0.80%
0
0.00%
-0.31%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
1.10%
0
0.00%
-0.12%
Bajaj Finserv Multi Cap Fund Direct-Growth
1.19%
0
0.00%
-0.14%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.61%
0
0.00%
-0.07%
Bandhan ELSS Tax Saver Fund Direct Plan-Growth
0.83%
0
0.00%
-0.04%
Bajaj Finserv Flexi Cap Fund Direct-Growth
1.03%
0
0.00%
-0.10%

Technical Indicators

RSI(14)
Neutral
28.28
ATR(14)
Less Volatile
52.60
STOCH(9,6)
Oversold
19.66
STOCH RSI(14)
Neutral
23.63
MACD(12,26)
Bearish
-9.15
ADX(14)
Strong Trend
35.32
UO(9)
Bearish
36.53
ROC(12)
Downtrend And Accelerating
-7.05
WillR(14)
Oversold
-86.79
Bearish
4
Neutral
3
Bullish
2

About GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Limited is an Indian subsidiary of UK-based GSK Plc, engaged in manufacturing, distributing, and trading pharmaceuticals. The company operates in three main product areas: vaccines, specialty medicines, and general medicines. It has manufacturing facilities in Nashik and Thane, with a clinical development center in Bangalore. The company's portfolio...more
Website
https://www.gsk-india.com
Chairperson NameRenu S. Karnad
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104